152 related articles for article (PubMed ID: 28112366)
1. Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis.
Yu M; Lu B; Liu Y; Me Y; Wang L; Li H
Mol Med Rep; 2017 Mar; 15(3):1103-1108. PubMed ID: 28112366
[TBL] [Abstract][Full Text] [Related]
2. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression.
Yu M; Lu B; Liu Y; Me Y; Wang L; Zhang P
Mol Med Rep; 2017 Feb; 15(2):689-695. PubMed ID: 28035413
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
5. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
6. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
8. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
9. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
[TBL] [Abstract][Full Text] [Related]
10. Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines.
Li X; Yin A; Zhang W; Zhao F; Lv J; Lv J; Sun J
Int J Mol Med; 2018 Nov; 42(5):2923-2929. PubMed ID: 30226554
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of TIM-3 in clear cell renal cell carcinoma.
Yuan J; Jiang B; Zhao H; Huang Q
Neoplasma; 2014; 61(1):35-40. PubMed ID: 24195506
[TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
13. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
14. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
Feng ZM; Guo SM
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
16. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway.
Yue G; Chen C; Bai L; Wang G; Huang Y; Wang Y; Cui H; Xiao Y
Mol Med Rep; 2019 Nov; 20(5):4551-4557. PubMed ID: 31702026
[TBL] [Abstract][Full Text] [Related]
18. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
19. Gelsolin inhibits the proliferation and invasion of the 786-0 clear cell renal cell carcinoma cell line in vitro.
Zhu X; Cai L; Meng Q; Jin X
Mol Med Rep; 2015 Nov; 12(5):6887-94. PubMed ID: 26398833
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine receptor kinase B silencing inhibits anoikis‑resistance and improves anticancer efficiency of sorafenib in human renal cancer cells.
Zhang P; Xing Z; Li X; Song Y; Zhao J; Xiao Y; Xing Y
Int J Oncol; 2016 Apr; 48(4):1417-25. PubMed ID: 26820170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
